Alimera Sciences Announces Equity Purchase Agreement for up to $20 Million with Lincoln Park Capital

NEXT STORY
BeyondSpring Announces Pricing of Ordinary Shares
PREV STORY
Helix BioPharma Corp. Announces Fiscal 2019 Year-End Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

SHAREHOLDER ALERT: Lowey Dannenberg, P.C. Files Securities Class Action Lawsuit Against Chembio Diagnostics, Inc. (NASDAQ: CEMI) Expanding the Class Period to Include March 12, 2020 Through June 16, 2020, and Encourages Investors to Inquire About the Lead Plaintiff Position Before the August 17, 2020 Lead Plaintiff Deadline

author_avatar
NASDAQ Market News

Onconova Therapeutics Announces Upcoming Presentation at the 3rd Annual RAS Targeted Drug Development Summit

author_avatar
NASDAQ Market News

AIM ImmunoTech Provides Third Quarter 2021 Business Update

author_avatar
NASDAQ Market News